H. Lundbeck A/S (CPH:HLUN.B)
33.70
+3.16 (10.35%)
May 14, 2025, 4:59 PM CET
H. Lundbeck Revenue
H. Lundbeck had revenue of 6.24B DKK in the quarter ending March 31, 2025, with 17.91% growth. This brings the company's revenue in the last twelve months to 22.95B, up 13.87% year-over-year. In the year 2024, H. Lundbeck had annual revenue of 22.00B with 10.51% growth.
Revenue (ttm)
22.95B
Revenue Growth
+13.87%
P/S Ratio
1.41
Revenue / Employee
4.03M
Employees
5,707
Market Cap
32.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.00B | 2.09B | 10.51% |
Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
Dec 31, 2020 | 17.67B | 636.00M | 3.73% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 303.14B |
Coloplast | 27.79B |
Genmab | 21.64B |
Demant | 22.42B |
ALK-Abelló | 5.71B |
Zealand Pharma | 55.69M |
Ambu A/S | 5.83B |
GN Store Nord | 17.67B |